Elan has received approval from the US Food and Drug Administration for ziconotide which is used in the treatment of chronic pain. Announcing the approval, Elan chairman and chief executive Mr Donal Geaney said the company is looking forward to working with the FDA.
Elan gets US drugs approval
Elan has received approval from the US Food and Drug Administration for ziconotide which is used in the treatment of chronic …
IN THIS SECTION
Martyn Turner
Dublin riots left north inner city youth ‘traumatised’ by the stigma of violence
Tom Toner obituary: Former chairman of Forfás who believed economic growth was a precondition for a fair society
How much does it cost to run a general election campaign?
General election ads: Meta complaint made over alleged failure to publish data
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning